Change in ANCA-levels at baseline vs 9 months in absolute (delta-)values.

NIAID Data Ecosystem2026-03-12 收录

数据链接：

https://figshare.com/articles/dataset/Change_in_ANCA-levels_at_baseline_vs_9_months_in_absolute_delta-_values_/13512671 数据链接链接失效反馈

官方服务：

资源简介：

Change in ANCA-levels at baseline vs 9 months in absolute (delta-)values.

创建时间：

2020-12-31

Additional file 1 of Longitudinal immune cell monitoring identified CD14++ CD16+ intermediate monocyte as a marker of relapse in patients with ANCA-associated vasculitis

活细胞监测

ANCA相关性血管炎

Additional file 1: Supplementary Fig. 1. Immuno-phenotyping strategy using antibody staining. Details of the gating strategies of (A) Panel 1 (helper T cell and follicular helper T cell), (B) Panel 2

DataCite Commons2020-08-25 更新90

Additional file 1: of The impact of intravenous methylprednisolone pulses on renal survival in anti-neutrophil cytoplasmic antibody associated vasculitis with severe renal injury patients: a retrospective study

ANCA相关性血管炎

肾脏研究

The dataset analyzed in the present study. (XLSX 33 kb)

Figshare2017-12-30 更新30

Data_Sheet_2_Relationship Between Gender and 1-Year Mortality in ANCA-Associated Vasculitis Patients: A Single-Center Retrospective Analysis and Meta-Analysis.docx

ANCA相关性血管炎

性别差异研究

ObjectiveThe relationship between gender and short-term prognosis of patients with anti-neutrophil cytoplasmic antibody (ANCA) associated vasculitis (AAV) is unclear, hence single-center retrospective

NIAID Data Ecosystem20

Supplementary Material for: Multi-organ Relapse Following COVID-19 in MPO-ANCA-Associated Vasculitis: A Case Report

ANCA相关性血管炎

COVID-19

Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a complex systemic autoimmune disease characterized by small vessel vasculitis. Typically, the relapse rate is lower in patie

DataCite Commons2023-10-25 更新80

Supplementary Material for: Efficacy and Safety of Avacopan in ANCA-Associated Vasculitis: A Meta-Analysis of Randomized Controlled Trials

ANCA相关性血管炎

药物安全性荟萃分析

Background: Avacopan, an oral C5a receptor antagonist, has been identified as a promising glucocorticoid-sparing agent in the management of ANCA-associated vasculitis (AAV). Although individual random

NIAID Data Ecosystem30

Change in ANCA-levels at baseline vs 9 months in absolute (delta-)values.

资源简介：

相关数据集